Revenue: The sum of all revenue fields included for a company's operating activities.
Stoke Therapeutics, Inc. (STOK) had Revenue of $9.32M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$9.32M |
$-61.62M |
|
-- |
|
$9.32M |
|
$74.75M |
|
$-65.43M |
|
$3.81M |
|
$-61.62M |
|
$-61.62M |
|
$-61.62M |
|
$-61.62M |
|
$-61.62M |
|
$-61.62M |
|
$-65.43M |
|
$-65.34M |
|
66.02M |
|
66.02M |
|
$-0.93 |
|
$-0.93 |
|
| Balance Sheet Financials | |
$322.54M |
|
$4.83M |
|
$71.43M |
|
$393.97M |
|
$41.93M |
|
-- |
|
$6.49M |
|
$48.42M |
|
$345.55M |
|
$345.55M |
|
$345.55M |
|
62.40M |
|
| Cash Flow Statement Financials | |
$-117.17M |
|
$59.71M |
|
$86.24M |
|
$84.94M |
|
$113.72M |
|
$28.78M |
|
$19.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-701.65% |
|
-701.65% |
|
-- |
|
-660.78% |
|
-660.78% |
|
$-119.50M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
1.07 |
|
84.15 |
|
-17.83% |
|
-17.83% |
|
-15.64% |
|
-17.83% |
|
$5.54 |
|
$-1.81 |
|
$-1.77 |
|